← Oncology Approval Tracker

FDA DECISION ·

Pemfexy

pemetrexed · Eagle Pharmaceuticals

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Ready-to-dilute pemetrexed for specified initial, maintenance or previously treated nonsquamous NSCLC uses and with cisplatin for unresectable malignant pleural mesothelioma or when curative surgery was unsuitable.

LAMPGEN ANALYSIS

Why it matters

Supplied pemetrexed as a liquid concentrate instead of a powder that requires reconstitution.

What research teams should watch

Update pharmacy preparation instructions and retain checks for folate, vitamin B12 and renal function.

PRIMARY RECORDS

Sources